Precision for Medicine acquires Hobart Group Holdings

Share this article:
Precision for Medicine acquires Hobart Group Holdings
Precision for Medicine acquires Hobart Group Holdings

Precision for Medicine has acquired Hobart Group Holdings, which specializes in strategic communications that address payer needs. Precision for Medicine, which has employees spread across six campuses in the US, launched in 2012 to “support next-generation approaches to drug development and commercialization.”

The Hobart Group started in 2003, and its offices in New Jersey, New York and Chicago, with their headcount of 140 employees, focus on payers, providers and distribution systems. Hobart Group founder Lisa Bair has left the company.

Hobart brings the experience of supporting more than 60 biopharmaceutical brands. “Bridging the value gap that often exists between the pharmaceutical and life sciences industry and its customers requires next generation approaches to scientific evidence, analytics and communications,” Hobart president Dan Renick and now Precision co-president and chief commercial officer said in a statement. “Precision is ideally positioned to help clients address these issues” he added.

Precision CEO Ethan Leder said in a statement that the acquisition addresses “the needs of the patient-centric multipayer landscape that characterizes modern healthcare.”

Neither party was available for comment by press time, so the impact this will have on headcount, if any, is uncertain.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?